Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
NVIDIA
NVDA
|
+$1B |
| 2 |
Netflix
NFLX
|
+$721M |
| 3 |
Apple
AAPL
|
+$468M |
| 4 |
UnitedHealth
UNH
|
+$422M |
| 5 |
GE Vernova
GEV
|
+$376M |
Top Sells
| 1 |
Broadcom
AVGO
|
+$673M |
| 2 |
Robinhood
HOOD
|
+$481M |
| 3 |
Meta Platforms (Facebook)
META
|
+$433M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$402M |
| 5 |
Palantir
PLTR
|
+$380M |
Sector Composition
| 1 | Technology | 19.67% |
| 2 | Healthcare | 15.34% |
| 3 | Consumer Discretionary | 12.38% |
| 4 | Financials | 11.51% |
| 5 | Industrials | 8.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3301
Xenetic Biosciences
XBIO
$4.7M
| $97K | ﹤0.01% |
24,750
-2,014
| -8% | -$7.9K |
|
3302
Reservoir Media
RSVR
$520M
| $96.6K | ﹤0.01% |
12,600
+200
| +2% | +$1.53K |
|
3303
Gulf Resources
GURE
$10.3M
| $96.4K | ﹤0.01% |
143,444
-4,738
| -3% | -$3.18K |
|
3304
Ryvyl
RVYL
$9.3M
| $95.3K | ﹤0.01% |
111,982
+73,000
| +187% | +$62.1K |
|
3305
Yunhong Green CTI Ltd
YHGJ
$16.7M
| $94.7K | ﹤0.01% |
111,566
-2,100
| -2% | -$1.78K |
|
3306
GT Biopharma
GTBP
$3.07M
| $94.2K | ﹤0.01% |
+26,300
| New | +$94.2K |
|
|
FLX
3307
BingEx Limited American Depositary Shares
FLX
$223M
| $93.2K | ﹤0.01% |
+29,600
| New | +$93.2K |
|
3308
Mesa Air Group
MESA
$53.2M
| $93.2K | ﹤0.01% |
100,200
-97,614
| -49% | -$90.8K |
|
|
YI
3309
111 Inc
YI
$49.4M
| $92.9K | ﹤0.01% |
13,014
+200
| +2% | +$1.43K |
|
3310
Stereotaxis
STXS
$262M
| $92.9K | ﹤0.01% |
43,800
-78,309
| -64% | -$166K |
|
3311
ABVC BioPharma
ABVC
$62.4M
| $92.8K | ﹤0.01% |
+41,706
| New | +$92.8K |
|
3312
Immunic
IMUX
$81.6M
| $92.2K | ﹤0.01% |
132,154
-537,310
| -80% | -$375K |
|
3313
Alpha Tau Medical
DRTS
$314M
| $91.7K | ﹤0.01% |
+29,400
| New | +$91.7K |
|
3314
Anixa Biosciences
ANIX
$96M
| $91.3K | ﹤0.01% |
27,673
+6,200
| +29% | +$20.5K |
|
3315
Pioneer Power Solutions
PPSI
$42.3M
| $91.1K | ﹤0.01% |
+33,144
| New | +$91.1K |
|
3316
Cue Biopharma
CUE
$59.9M
| $91.1K | ﹤0.01% |
133,464
+96,518
| +261% | +$65.9K |
|
3317
Bridgford Foods
BRID
$72.2M
| $90.9K | ﹤0.01% |
11,500
| – | – |
|
|
LGO
3318
Largo
LGO
$95.6M
| $90.7K | ﹤0.01% |
70,300
+34,900
| +99% | +$45K |
|
3319
Relmada Therapeutics
RLMD
$53.1M
| $90.1K | ﹤0.01% |
150,100
+26,000
| +21% | +$15.6K |
|
3320
SemiLEDS
LEDS
$14.8M
| $89.3K | ﹤0.01% |
34,100
+18,200
| +114% | +$47.7K |
|
3321
Carver Bancorp
CARV
$14.9M
| $87K | ﹤0.01% |
50,300
+3,800
| +8% | +$6.57K |
|
3322
Castor Maritime
CTRM
$19M
| $87K | ﹤0.01% |
40,669
+1,000
| +3% | +$2.14K |
|
3323
DarioHealth
DRIO
$23M
| $87K | ﹤0.01% |
6,490
+610
| +10% | +$8.17K |
|
3324
Equillium
EQ
$112M
| $86.4K | ﹤0.01% |
274,100
+4,600
| +2% | +$1.45K |
|
|
STRM
3325
DELISTED
Streamline Health Solutions
STRM
| $84.9K | ﹤0.01% |
16,357
-300
| -2% | -$1.56K |
|